Lixte Biotechnology Holdings, Inc. entered into an Allocation Deed and Consultancy Agreement on February 12 and 13, 2026, respectively, with Liora Technologies Europe Ltd. and Sidney Braun, appointing him as Liora's board member and CEO with specified compensation and a 20% net purchase price allocation upon sale. The company issued a press release on February 18, 2026, announcing the appointment.
Key takeaways
Entered Allocation Deed on February 12, 2026, between Company, Liora, and Sidney Braun
Entered Consultancy Agreement on February 13, 2026, appointing Sidney Braun as Liora CEO and board member
Signing bonus of GBP 50,000 exclusive of VAT; monthly retainer of GBP 25,000 exclusive of VAT
20% of net purchase price to Consultant upon Sale of Liora or Liora Successor
Press release issued February 18, 2026, announcing appointment